GGrantIndex
← Leaderboards

Stella Margaret Davies

University Of Minnesota Twin Cities

Google Scholar ↗PubMed ↗ORCID ↗
$7,181,470
Attributed
$13,477,825
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY2005–25
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,477,825 · 7

By mechanism

R01$9,599,290 · 3
U01$3,868,652 · 2
M01$9,883 · 2

Top collaborators

Most similar at University Of Minnesota Twin Cities

Same institution · by research overlap

Others in their field

Top investigators on “Future”

Research focus

FutureChildIncidenceResponseStem Cell TransplantHematopoietic Stem Cell TransplantationTransplantationComplicationMorbidity - Disease RateTransplant RecipientsFrequenciesFailureScheduleResourcesEnrollmentBone Marrow TransplantationGenetic PolymorphismExposure ToInvestigationDiagnosisInstitutionCohortBone MarrowCohort Studies

Grant awards (23)

TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.$1,447,360
R01 · FY2025 · HL · contact PI
Randomized trial of viral specific T-cell infusion to prevent viral infection after hematopoietic stem cell transplant.$533,505
U01 · FY2025 · AI · contact PI
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.$1,418,412
R01 · FY2024 · HL · contact PI
Randomized trial of viral specific T-cell infusion to prevent viral infection after hematopoietic stem cell transplant.$753,425
U01 · FY2024 · AI · contact PI
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.$1,447,360
R01 · FY2023 · HL · contact PI
Randomized trial of viral specific T-cell infusion to prevent viral infection after hematopoietic stem cell transplant.$753,425
U01 · FY2023 · AI · contact PI
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.$1,453,734
R01 · FY2022 · HL · contact PI
Randomized trial of viral specific T-cell infusion to prevent viral infection after hematopoietic stem cell transplant.$753,425
U01 · FY2022 · AI · contact PI
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.$1,484,514
R01 · FY2021 · HL · contact PI
Randomized trial of viral specific T-cell infusion to prevent viral infection after hematopoietic stem cell transplant.$663,928
U01 · FY2021 · AI · contact PI
Prediction Model for Radiation Sensitivity in Children with Cancer$185,017
U01 · FY2010 · CA · contact PI
Prediction Model for Radiation Sensitivity in Children with Cancer$225,927
U01 · FY2009 · CA · contact PI
CLINICAL TRIAL: AMD-3100 IN PATIENTS WITH FANCONI ANEMIA$9,363
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: FANCONI ANEMIA AUTOLOGOUS REINFUSION AND RESEARCH COLLECTION$520
M01 · FY2008 · RR · contact PI
Host factors and etiology of leukemia$258,987
R01 · FY2006 · CA · contact PI
Host factors and etiology of leukemia$331,525
R01 · FY2005 · CA
Host factors and etiology of leukemia$331,525
R01 · FY2004 · CA
Host factors and etiology of leukemia$331,525
R01 · FY2003 · CA
Host factors and etiology of leukemia$326,528
R01 · FY2002 · CA
THERAPY-RELATED LEUKEMIA--CLINICAL/BIOLOGIC PREDICTORS$142,499
R01 · FY2002 · CA
THERAPY-RELATED LEUKEMIA--CLINICAL/BIOLOGIC PREDICTORS$125,719
R01 · FY2002 · CA
THERAPY-RELATED LEUKEMIA--CLINICAL/BIOLOGIC PREDICTORS$253,493
R01 · FY2001 · CA
THERAPY-RELATED LEUKEMIA--CLINICAL/BIOLOGIC PREDICTORS$246,109
R01 · FY2000 · CA